IRUXOL◊ MONO Collagenase Ointment 1.2U
Enzymatic debridement of necrotising wounds
Your choice for gentle and selective debridement
IRUXOL MONO Ointment is an enzyme-based product that acts selectively on collagen, freeing the wound of necrotic material so that healing can progress. Its active component, collagenase, helps break down native collagen in the wound and has been shown to remove of necrotic tissue from the wound bed.1-3
- Selective: Acts selectively on collagen2
- Effective: Supported by more than 20 years of successful use on a variety of chronic wound types1
Product features
Application and PDF overview
Related technologies
Medical Education
Customer information
Indications
IRUXOL MONO Ointment contains clostridiopeptidase (a collagenase enzyme) and protease enzymes.
These enzymes can be used to remove dead tissue (debride) from wounds such as leg ulcers, diabetic ulcers and pressure sores. By removing the dead tissue, IRUXOL MONO Ointment cleanses the wound and speeds up wound healing.
Contraindications
Do not use IRUXOL MONO Ointment if you are allergic to protease enzymes or any of the other ingredients of this medicine (listed in IFU).
Take special care with IRUXOL MONO Ointment if:
you are diabetic and have been told that the wound contains dry gangrenous material.
If you are using other medicines please see following section.
Using other medicines
IRUXOL MONO Ointment should not be used if you are applying other products to the wound that may interfere with the medicine such as: antiseptics, antibiotics (tyrothricin, gramicidin and tetracyclines), heavy metals, detergents and soaps.
Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Pregnancy and breast-feeding
Do not use IRUXOL MONO Ointment if you know, or think you may be, less than three months pregnant, unless the doctor has told you to. The ointment is safe to use if you are more than three months pregnant and while breast-feeding. Ask your doctor or pharmacist for advice before taking or using any medicines.
Citations
- Marazzi et al . Journal of Wound Care. Vol 15 , No.5 , May 2006.
- Demidova-Rice et al. Adv Skin Wound Care. 2012 July ; 25(7): 304–314.
- Burgos A et al. .Clin Drug Invest 2000 Jun; 19 (6): 399-407.